Cargando…
The Rheumatology Drugs for COVID-19 Management: Which and When?
Introduction: While waiting for the development of specific antiviral therapies and vaccines to effectively neutralize the SARS-CoV2, a relevant therapeutic strategy is to counteract the hyperinflammatory status, characterized by an increase mainly of interleukin (IL)-1β, IL-2, IL-6, IL-7, IL-8, and...
Autores principales: | Atzeni, Fabiola, Masala, Ignazio Francesco, Rodríguez-Carrio, Javier, Ríos-Garcés, Roberto, Gerratana, Elisabetta, La Corte, Laura, Giallanza, Manuela, Nucera, Valeria, Riva, Agostino, Espinosa, Gerard, Cervera, Ricard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919806/ https://www.ncbi.nlm.nih.gov/pubmed/33669218 http://dx.doi.org/10.3390/jcm10040783 |
Ejemplares similares
-
Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases
por: Nucera, Valeria, et al.
Publicado: (2021) -
Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
por: Atzeni, Fabiola, et al.
Publicado: (2021) -
Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis
por: Atzeni, Fabiola, et al.
Publicado: (2023) -
Frequency of Renal Function Parameter Abnormalities in Patients with Psoriatic Arthritis and Rheumatoid Arthritis: Real-World Evidence from Clinical Practice
por: Atzeni, Fabiola, et al.
Publicado: (2022) -
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study
por: Barbieri, Maria Antonietta, et al.
Publicado: (2020)